stock decline

Trip.com investors with $100K+ losses must file lead plaintiff claims by May 11, 2026 in securities lawsuit stemming from China's antitrust investigation.

Oracle stock has crashed over 50% in six months amid AI spending concerns, but strong revenue growth and record $553B backlog signal potential recovery opportunity.

Vital Farms stock fell 10.8% on February 26 after weak earnings, triggering securities litigation investigation by Rosen Law Firm over alleged disclosure violations.

RWC Asset Advisors liquidates entire $33M Li Auto stake as Chinese EV maker faces 38% annual decline amid weak earnings and intense competition.

BBB's National Advertising Division found Freshpet's marketing claims misleading. Stock fell 11% to $67.42. Securities lawyers investigating potential violations.

Securities fraud lawsuit filed against Alight (ALIT) alleges executives misrepresented growth and sales execution while stock collapsed 56% over 15 months.

ASML stock dropped 3.3% despite Goldman Sachs upgrade and strong earnings from major customers Micron and Nvidia, suggesting valuation concerns override positive fundamentals.

Park Presidio Capital reduces Floor & Decor stake by $13.94M as home improvement retailer faces 5% comparable sales drop and mortgage rate headwinds.

Hub Group shares fell 34% after accounting restatement, but Broad Bay Capital Management initiated a $30.42M stake, suggesting market overreaction.

Class action lawsuit filed against $EOSE over missed production targets and guidance misses. Stock crashed 39% after $970M loss reported.

Soleno Therapeutics faces securities lawsuit after hyperphagia drug VYKAT XR launch falters amid safety concerns, driving shares down 40% since August short seller report.

SoundHound AI stock fell 7% after CFO Nitesh Sharan departed for quantum computing; co-founder James Horn assumes interim role amid investor concerns.

$ODD stock crashes 49% after revealing 30% Q1 revenue decline tied to advertising partner algorithm shift. Securities lawsuit filed over disclosure failures.

Class actions filed against $PYPL over false revenue projections and $RGENX after FDA clinical hold on gene therapy following safety concerns.

Calydon Capital sells $9.2M ZoomInfo stake amid 92% stock decline since 2021, signaling investor pessimism over stalled sales growth.

Paysafe Limited faces securities fraud lawsuit after missing Q3 revenue by $5.8M, reporting $87.7M loss. Stock plummeted 27.6% on undisclosed risks.

NuScale Power faces securities fraud lawsuit after disclosing $495M payment to inexperienced nuclear startup ENTRA1 Energy, triggering 12.4% stock decline.

Class action lawsuit filed against $ALIT alleging executives made false statements about growth and cost cuts while concealing sales execution failures.

SoFi CEO buys stock at $17.32 following Muddy Waters short report. Company reports record Q4 revenue and ninth consecutive quarter of GAAP profitability.

Nektar Therapeutics faces class action lawsuit over alleged failure to disclose enrollment protocol violations in failed Phase 2b REZOLVE-AA trial, triggering 8% stock decline.